KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the presentation of novel sebetralstat data related to ...

"The effect of formula supplementation spans beyond cow's milk allergy," Bhasin said, citing a prior randomized trial showing ...

Omalizumab is superior to oral immunotherapy (OIT) for multifood allergy, and most patients include dietary consumption (DC) ...

In a cohort of nearly 300 pediatric patients with cystic fibrosis, food allergy was found in less than 4% of the population, ...

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...

FARE to Debut Two New Videos at AAAAI/WAO Joint Congress, Including PSA on Early Allergen Introduction and Documentary on ...

Infants who did not exclusively feed on colostrum during their first 3 days of life were more likely to develop egg or peanut ...

SAN DIEGO -- Common triggers for food protein-induced enterocolitis syndrome (FPIES) have shifted, and more cases than ...

A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new positive data from Stage 2 and Stage ...

Roche’s asthma drug Xolair appears to be safer and more effective than oral immunotherapy at treating adults and children ...